Myasthenia Gravis Disease Market Growth Outlook: Treatment Innovations and Emerging Opportunities
Valued at USD 2.60 billion in 2024, the myasthenia gravis disease market is projected to reach USD 2.83 billion in 2025 and USD 6.19 billion by 2034, growing at a CAGR of 9.1% during the forecast period 2025–2034. Growth is driven by the increasing global prevalence of myasthenia gravis, advancements in diagnostic techniques, and the development of innovative therapies. Key players...
0 Commentarios 0 Acciones 221 Views 0 Vista previa